Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
Yeah, I've definitely noticed a shift in how expenses are being looked at here at AbbVie. It's not just your team. We had a similar deep dive into our Q3 spending, and it felt like we were justifying things we've been doing for years. It's creating a lot of uncertainty, and honestly, a bit of a drag on morale when you feel like every penny is being scrutinized. Hopefully, it's a short-term thing to address specific concerns, but it's making forward planning feel like a guessing game.
This budget intensity you're describing sounds familiar. While I can't speak to specific departments, there's definitely a palpable atmosphere of tighter financial controls across the board. It's a bit of a balancing act, isn't it? On one hand, efficiency is key, but on the other, this level of scrutiny can stifle innovation and make day-to-day operations feel unnecessarily complicated. Good luck navigating it; it’s a challenging time for sure.